Amarin Corp Plc (AMRN)

[amarininvestor]

HDG,

OK I see. your point now, and it is a fair point. However, there are so many issues with the current ruling that I am hopeful that is reversed in the USA. With respect to other countries, I see how this could encourage generics to try to invalidate the patents in other countries but I continue to believe that if the proper standard is applied, the chances in other countries to invalidate the patents are similar to what we thought before March-30th....that would be very low.

Therefore my thoughts with respect to your question ( the chances being lower, equal, or higher) I would say that it would be fully independent of what happened in the USA, and therefore if the generics feel encouraged to try, their chances of success would be low (as we thought before the ruling here in the USA)